Browsing Tag
NYSE
114 posts
Why CONMED’s (NYSE: CNMD) reported sale review could reset the medtech value debate after Q2
CONMED’s sale speculation, Q2 results and AirSeal update put CNMD back in focus. Read how medtech M&A interest could reshape its turnaround story.
CubeSmart (NYSE: CUBE) lifts 2026 outlook as same-store NOI still falls 0.7% and payout ratio rises
CubeSmart raised 2026 guidance and formed a $197M Heitman JV, but same-store NOI still fell 0.7% and the FFO payout ratio climbed to 84.1% from 80.0%.
TechnipFMC delivers 21% EBITDA margin as subsea execution accelerates, but $10bn order target now hinges on H2
TechnipFMC Q2 2026: revenue $2.76B, adj EPS $0.91, Subsea margin 23.2%. Guidance held, but $10B order target now needs $5.6B of H2 Subsea inbound.
Boston Scientific (BSX) Q2 2026 beats estimates as MiRus TAVR investment reshapes strategy
Boston Scientific lifted FY 2026 guidance and disclosed a $1.5B MiRus TAVR bet, but BSX trades near 52-week lows as softer Q3 growth guidance stings.
Coca-Cola (NYSE: KO) Q2 2026: Braun’s first full quarter delivers 7% revenue growth
Coca-Cola raised 2026 EPS growth to 9-10% after Q2 volume climbed 5%, pricing added 2 points and comparable operating margin widened to 35.6% year on year.
CenterPoint Energy (CNP) Q2 2026 beats: Houston load queue swells to 14 GW, capex plan lifted $1.2bn
CenterPoint Energy submits 14 GW of Houston load via ERCOT Batch Zero, a 65% jump over current peak, and lifts its 10-year capex plan to $66.7 billion.
STMicroelectronics (STM) guides Q3 revenue below consensus even as 2027 data centre target crosses $2bn
STMicroelectronics missed Q3 revenue consensus but lifted its 2027 data centre target above $2 billion, testing investor patience on margin recovery.
Alcoa (NYSE: AA) approves Australia gallium project with US-Japan-Australia backing
Alcoa (NYSE: AA) reaches FID on 100-tonne Wagerup gallium plant with US, Japan and Australia backing under the $13bn allied critical minerals framework.
DigitalOcean (DOCN) Q2 RPO tops $800m, 10X YoY on nine-figure AI customer wins
DigitalOcean (DOCN) up 9.3% as Q2 RPO tops $800M, 10X YoY on nine-figure AI wins. Growth accelerates to 29%, capacity extends into 2028.
Levi Strauss (LEVI) delivers Q2 2026 double beat and raises FY revenue growth to 7-7.5%
Levi Strauss (LEVI) delivers Q2 double beat, raises FY revenue growth to 7-7.5% and lifts dividend 14%. Tariff-adjusted guidance signals margin recovery ahead.